{"id": "1387746247461773312", "creation": 1619699463.0, "user_id": "2283733573", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 4, "quote_count": 0}}, "text": "#OpenAccess #COVID19 #research from @TheLancetOncol. Safety and immunogenicity of one versus two doses of the COVID-19 #vaccine BNT162b2 for patients with #cancer: interim analysis of a prospective observational study. https://t.co/uqqQtPzugt. @Blackyclawson @mrsjoannalyle https://t.co/PHce50sJzB", "first_save": 1634559108.199414, "hashtags": ["#OPENACCESS", "#COVID19", "#RESEARCH", "#VACCINE", "#CANCER"]}